Darbepoetin alfa for the treatment of anemic patients with low- and intermediate-1-risk myelodysplastic syndromes von Stasi, R., Abruzzese, E., Lanzetta, G., Terzoli, E., Amadori, S.

Volltext

P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: Distribution and prognostic relevance von Torsello, A, Garufi, C, Cosimelli, M, Diodoro, M.G, Zeuli, M, Vanni, B, Campanella, C, D’Angelo, C, Sperduti, I, Donnorso, R. Perrone, Cognetti, F, Terzoli, E, Mottolese, M

Volltext

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials von Ferretti, G, Bria, E, Giannarelli, D, Felici, A, Papaldo, P, Fabi, A, Di Cosimo, S, Ruggeri, E M, Milella, M, Ciccarese, M, Cecere, F L, Gelibter, A, Nuzzo, C, Cognetti, F, Terzoli, E, Carlini, P

Volltext

Cancer-related fatigue: Evolving concepts in evaluation and treatment von STASI, Roberto, ABRIANI, Luca, BECCAGLIA, Patrizia, TERZOLI, Edmondo, AMADORI, Sergio

Volltext

Once-weekly dosing of recombinant human erythropoietin alpha in patients with myelodysplastic syndromes unresponsive to conventional dosing von Stasi, R., Brunetti, M., Terzoli, E., Abruzzese, E., Amadori, S.

Volltext

Factorial design for randomized clinical trials von Bria, E, Di Maio, M, Nisticò, C, Cuppone, F, Terzoli, E, Cognetti, F, Giannarelli, D

Volltext

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer von Cresta, S., Grasselli, G., Mansutti, M., Martoni, A., Lelli, G., Capri, G., Buzzi, F., Robustelli Della Cuna, G., Jirillo, A., Terzoli, E., Frevola, L., Tarenzi, E., Sguotti, C., Azli, N., Murawsky, M., Gianni, L.

Volltext

Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma von Granda, T G, D'Attino, R-M, Filipski, E, Vrignaud, P, Garufi, C, Terzoli, E, Bissery, M-C, Lévi, F

Volltext

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients von Garufi, C, Bria, E, Vanni, B, Zappalà, A M R, Sperduti, I, Terzoli, E

Volltext

Skin testing and hypersensitivity reactions to oxaliplatin von Garufi, C., Cristaudo, A., Vanni, B., Bria, E., Aschelter, A. M., Santucci, B., Terzoli, E.

Volltext

Immunohemolytic anemia following oxaliplatin administration von Garufi, C., Vaglio, S., Brienza, S., Conti, L., D'Attino, R. M., Girelli, G., Terzoli, E.

Volltext

Single-agent oxaliplatin in pretreated advanced breast cancer patients: A phase II study von Garufi, C., Nisticò, C., Vaccaro, A., D'Ottavio, A., Zappalà, A. R., Aschelter, A. M., Terzoli, E.

Volltext

Non-small cell lung cancer: early stages von Bria, E., Ceribelli, A., Trovò, M.G., Gelibter, A., Gigante, M., Calabrò, E., Cuppone, F., Cognetti, F., Terzoli, E., Pastorino, U.

Volltext

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer von Van Cutsem, E., Pozzo, C., Starkhammar, H., Dirix, L., Terzoli, E., Cognetti, F., Humblet, Y., Garufi, C., Filez, L., Gruia, G., Cote, C., Barone, C.

Volltext

Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening? von Ferretti, G, Bria, E, Carlini, P, Felici, A, Giannarelli, D, Cuppone, F, Papaldo, P, Nisticò, C, Fabi, A, Gelibter, A, Terzoli, E, Cognetti, F

Volltext

Pilot study of celecoxib and infusional 5‐fluorouracil as second‐line treatment for advanced pancreatic carcinoma von Milella, Michele, Gelibter, Alain, Cosimo, Serena Di, Bria, Emilio, Ruggeri, Enzo Maria, Carlini, Paolo, Malaguti, Paola, Pellicciotta, Mario, Terzoli, Edmondo, Cognetti, Francesco

Volltext

Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide von PAPALDO, Paola, LOPEZ, Massimo, CARHNI, Paolo, NISTICO, Cecilia, CONTI, Francesca, DI LAURO, Luigi, BOTTI, Claudio, DI FILIPPO, Franco, FABI, Alessandra, GIANNARELLI, Diana, CALABRESI, Federico, MAROLLA, Paolo, CORTESI, Enrico, ANTIMI, Mauro, TERZOLI, Edmondo, VIA, Patrizia, BARONE, Carlo, FERRETTI, Gianluigi, DI COSIMO, Serena

Volltext

Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients von Pace, A, Bove, L, Nisticò, C, Ranuzzi, M, Innocenti, P, Pietrangeli, A, Terzoli, E, Jandolo, B

Volltext

Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer von Nisticò, C., Garufi, C., Barni, S., Frontini, L., Gallà, D. A. P., Giannarelli, D., Vaccaro, A., D'Ottavio, A. M., Terzoli, E.

Volltext

Response to recombinant human erythropoietin in patients with myelodysplastic syndromes von STASI, R, BRUNETTI, M, BUSSA, S, CONFORTI, M, DI GIULIO, C, CRESCENZI, A, TERZOLI, E, VECCHIONE, A, PAGANO, A

Volltext